Pascal Soriot, AstraZeneca CEO (David Zorrakino/Europa Press via AP)
September 13, 2022 02:29 PM EDTUpdated 03:26 PM
Pharma
Law

As­traZeneca wins fed­er­al class-ac­tion suit, judge dis­miss­es share­hold­er­s' mis­lead­ing claims

Paul Schloesser

Associate Editor

As­traZeneca nev­er got its Covid-19 vac­cine au­tho­rized in the US, and while share­hold­ers have tried tak­ing the UK phar­ma to court, a judge has now …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times